AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trivofid 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Fidelity Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Trivofid 1mg/500mg/0.2mg Tablet SR

Diabetol Plus 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping to regulate blood glucose. Diabetol Plus should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar or well-being; discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive treatment plan incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Trivofid 1mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Trivofid 1mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. The Trivofid 1mg/500mg/0.2mg sustained-release tablet should be consumed on an empty stomach.

Common Side effects of Trivofid 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Trivofid 1mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Trivofid 1mg/500mg/0.2mg Tablet SR on an empty stomach.

How Trivofid 1mg/500mg/0.2mg Tablet SR works:

Trivofid SR tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formula.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Trivofid 1mg/500mg/0.2mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Trivofid 1mg/500mg/0.2mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Trivofid tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The extended-release Trivofid 1mg/500mg/0.2mg tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. Medical advice is necessary. Furthermore, Trivofid 1mg/500mg/0.2mg Tablet SR is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Trivofid 1mg/500mg/0.2mg SR tablets. Dosage modification may be necessary; physician consultation is advised. For those with mild to moderate hepatic dysfunction, a low initial dose is typically recommended. Trivofid 1mg/500mg/0.2mg SR tablets are contraindicated in patients with severe liver disease.

What if you forget to take Trivofid 1mg/500mg/0.2mg Tablet SR :

Should you forget a Trivofid 1mg/500mg/0.2mg SR Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Trivofid 1mg/500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Trivofid 1mg/500mg/0.2mg Tablet SR

Trivofid 1mg/500mg/0.2mg SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Trivofid 1mg/500mg/0.2mg SR tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Trivofid 1mg/500mg/0.2mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Trivofid 1mg/500mg/0.2mg SR Tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Trivofid 1mg/500mg/0.2mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Trivofid 1mg/500mg/0.2mg ...
82
MRP 100
18% off